Skip to main content
Publish date:

Flexion Therapeutics To Present At The 29th Annual Credit Suisse Virtual Healthcare Conference

BURLINGTON, Mass., Nov.

BURLINGTON, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 29 th Annual Credit Suisse Virtual Healthcare Conference. The virtual fireside chat is scheduled to begin at 8:45 a.m. ET on Wednesday, November 11, 2020.

To access the live webcast of the presentation, please visit the Flexion website at  http://ir.flexiontherapeutics.com.

About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

Contact:

Scott YoungVice President, Corporate Communications & Investor RelationsFlexion Therapeutics, Inc.T: 781-305-7194syoung@flexiontherapeutics.com